Corbus Pharmaceuticals Holdings (CRBP) Other Operating Expenses (2021)

Corbus Pharmaceuticals Holdings (CRBP) recorded quarterly Other Operating Expenses of $9.4 million in Q4 2021.

Corbus Pharmaceuticals Holdings (CRBP) Other Operating Expenses (2021) Analysis & Trends

Corbus Pharmaceuticals Holdings' Other Operating Expenses history runs 1 years deep, the most recent figure standing at $9.4 million for Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn -
7 Psyence Biomedical 251.43 Bn 251.42 Bn -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn
9 Abivax 94.37 Bn 94.37 Bn -
10 Corbus Pharmaceuticals Holdings 133.67 Mn 105.86 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2021 9.39 Mn